← All medicines
Augmentin Paediatric 125 mg/31.25 mg per 5 ml Powder for Oral Suspension
Licence PA1077/093/004 · Marketed
- Licence holder
- GlaxoSmithKline (Ireland) Limited (all products →)
- Active substances
- Amoxicillin, Clavulanic acid
- Dosage form
- Powder for oral suspension
- Route of administration
- Oral use
- ATC codes
- J01CR, J01CR02
- First authorised
- 28/07/1983
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Full application (Article 8(3) of Directive No 2001/83/EC)
Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 04 Jul 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.